Nigeria is set to introduce the measles-rubella vaccine into its national immunization program in 2025, marking a significant step towards preventing congenital defects and improving public health. This initiative comes after sustained advocacy efforts by organizations like the Centre for Well-Being and Integrated Nutrition Solutions (C-WINS), which have been working closely with government agencies and stakeholders to ensure widespread acceptance of the vaccine.
Rubella infections during pregnancy pose a serious threat to newborn health, leading to congenital defects such as blindness, deafness, and heart defects. Despite being a preventable condition, rubella remains a challenge due to low vaccination rates in Nigeria. The country’s measles vaccination coverage is between 50% and 60%, significantly below the 95% needed for herd immunity.
C-WINS and other organizations have been collaborating with the National Primary Health Care Development Agency and the Nigeria Governors’ Spouses Forum to boost awareness and mobilize communities. First Ladies from several states have launched public awareness campaigns to drive community engagement and support for the vaccine rollout.
The success of this initiative depends on timely financial and logistical commitments from federal and state governments, including vaccine transportation, storage, training of health workers, and deployment of immunization personnel. The Global Alliance for Vaccines and Immunization (Gavi) has provided support to make the vaccine accessible to Nigerians.
Nigeria’s introduction of the measles-rubella vaccine aligns with global efforts to combat these diseases. As of now, 175 out of 194 WHO member states have adopted the rubella vaccine, highlighting Nigeria’s readiness to join the global community in addressing this health challenge. The campaign aims to achieve substantial economic and social benefits by saving lives, reducing healthcare costs, and preventing lifelong disabilities.
